Kyungdong's Reductil modified new drug to be soon approved.

Published: 2007-07-19 06:58:00

Updated: 2007-07-19 06:58:00

Kyungdong pharmaceutical company announced on July 13 that a modified drug of sibutramine (Reductil), an anti-obesity drug, called Silumin capsule would be approved by the KFDA shortly around the coming Oct.

Kyungdong said that they successfully completed the clinical studies over the new deri...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK